BI Asset Management Fondsmaeglerselskab’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,586
Closed -$502K 798
2025
Q1
$502K Sell
11,586
-8,704
-43% -$441K 0.01% 572
2024
Q4
$1.14M Buy
20,290
+17,630
+663% +$1.1M 0.01% 486
2024
Q3
$181K Buy
+2,660
New +$150K ﹤0.01% 534
2024
Q2
Sell
-5,475
Closed -$378K 670
2024
Q1
$378K Sell
5,475
-238
-4% -$15.1K 0.01% 581
2023
Q4
$423K Sell
5,713
-36,605
-86% -$2.4M 0.01% 570
2023
Q3
$2.89M Buy
42,318
+35,093
+486% +$2.98M 0.07% 212
2023
Q2
$678K Buy
7,225
+4,633
+179% +$361K 0.02% 427
2023
Q1
$176K Buy
2,592
+275
+12% +$17.7K ﹤0.01% 609
2022
Q4
$115K Buy
+2,317
New +$94.7K ﹤0.01% 597
2020
Q4
Sell
-275
Closed -$28K 419
2020
Q3
$28K Buy
+275
New +$23.7K ﹤0.01% 451
2019
Q4
Sell
-12,652
Closed -$1.14M 357
2019
Q3
$1.14M Buy
+12,652
New +$1.44M 0.06% 220

Other funds holding EXAS

BI Asset Management Fondsmaeglerselskab's EXAS Position: Q2 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 11,586 shares — an estimated $502K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in EXAS in Q3 2019 and held it in 11 quarters. The position peaked at $2.89M in Q3 2023. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 11,586 Exact Sciences shares in Q2 2025, an estimated $502K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Exact Sciences in Q3 2019 and held it in 11 quarters.
  • BI Asset Management Fondsmaeglerselskab's Exact Sciences position peaked at $2.89M in Q3 2023.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2025, filed 14 Aug 2025.